Results 11 to 20 of about 165,686 (209)

Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients

open access: yesCancer Control, 2021
Objectives Vancomycin-resistant enterococcus infections impact mortality in oncology patients. Given the low rate of vancomycin-resistant enterococcus bacteremia, low virulence of vancomycin-resistant enterococcus, and advent of rapid diagnostic systems,
Matthew Snyder PharmD   +2 more
doaj   +1 more source

Direct replacement of antibodies with molecularly imprinted polymer (MIP) nanoparticles in ELISA - development of a novel assay for vancomycin [PDF]

open access: yes, 2013
A simple and straightforward technique for coating microplate wells with molecularly imprinted polymer nanoparticles (nanoMIPs) to develop ELISA type assays is presented here for the first time.
Guerreiro, Antonio R.   +7 more
core   +1 more source

Resveratrol Ameliorates Vancomycin-Induced Testicular Dysfunction in Male Rats

open access: yesMedicina, 2023
Background and Objectives: Numerous studies have indicated that antibiotics may adversely affect testicular and sperm function. As an alternative to penicillin, vancomycin is a glycopeptide antibiotic developed to treat resistant strains of ...
Fahad S. Alshehri
doaj   +1 more source

Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States [PDF]

open access: yes, 2012
This research was supported in part with federal funds from the NIAID/NIH/DHHS, including the Harvard-wide Program on Antibiotic Resistance (NIH grant AI083214), NIH grant EY017381 (M.S.G.), contract HHSN27220090018C, and the NARSA program supported ...
Griggs, Allison   +34 more
core   +1 more source

The Nephrotoxicity of Vancomycin [PDF]

open access: yesClinical Pharmacology & Therapeutics, 2017
Vancomycin use is often associated with nephrotoxicity. It remains uncertain, however, to what extent vancomycin is directly responsible, as numerous potential risk factors for acute kidney injury frequently coexist. Herein, we critically examine available data in adult patients pertinent to this question.
Filippone, Edward J.   +2 more
openaire   +2 more sources

Vancomycin-induced severe thrombocytopenia in a young infant [PDF]

open access: yes, 2018
Vancomycin is a first-line drug for treating methicillin-resistant Staphylococcus aureus. Thrombocytopenia is a rare adverse reaction to vancomycin treatment, and there are no reports of vancomycin-induced thrombocytopenia (VIT) in infants.
Jian-hui Yang (6045239)   +4 more
core   +1 more source

Vancomycin tolerance in Gram-positive cocci [PDF]

open access: yes, 2011
Vancomycin, a glycopeptide antimicrobial agent, represents the last line of defence against a wide range of multi-resistant Gram-positive pathogens such as enterococci, staphylococci and streptococci.
Moscoso, Miriam   +2 more
core   +1 more source

Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role

open access: yesInfection and Drug Resistance, 2021
Xiao Li,1,* Wen Xu,1,* Ran Li,2 Qie Guo,1 Xiangpeng Li,1 Jialin Sun,1 Shuhong Sun,1 Jing Li1 1Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266003, People’s Republic of China; 2Department of ...
Li X   +7 more
doaj  

Vancomycin- and Strontium-Loaded Microspheres with Multifunctional Activities against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration [PDF]

open access: yes, 2019
Biomaterials that have capacities to simultaneously induce bone regeneration and kill bacteria are in demand because bone defects face risks of severe infection in clinical therapy.
Pengfei Wei (662637)   +10 more
core   +1 more source

Oral vancomycin desensitisation to treat Clostridium difficile infection in a vancomycin allergic patient

open access: yesWorld Allergy Organization Journal, 2013
The prevalence of Clostridium difficile infection (CDI) is increasing worldwide. Oral vancomycin is an effective and frequently used treatment. However, patients with CDI who are allergic to intravenous vancomycin cannot receive oral vancomycin due to ...
Shanti Mahabir   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy